Get started

Fibonacci

ALIVUS LIFESCIENCESStock Overview: Alivus Life Sciences Ltd, NSE, current price: ₹1,061.65. Alivus Life Sciences Ltd specializes in pharmaceuticals and life sciences, focusing on drug development and healthcare products. Key Levels: Support level (Yellow Zone): ₹817.40 Swing zone (Green Zone): ₹928.00 - ₹1,046.50 Target levels (T): T1: ₹1,275.10, T2: ₹1,385.75, T3: ₹1,526.70, Final target: ₹1,933.70 Technical Indicators: RSI (Relative Strength Index): Currently at 51.14, indicating neutral momentum as it is neither overbought nor oversold. Volume: Significant spikes during price movements, reflecting strong trading activity and investor interest. MA (Moving Average): The stock price is above the 200-period moving average, suggesting a long-term bullish trend. Sector and Market Context: The pharmaceutical sector has demonstrated resilience and growth potential due to ongoing healthcare demands. Alivus Life Sciences Ltd's performance aligns with this trend, showing cautious optimism in a market focused on stable growth sectors. Risk Considerations: Potential risks include regulatory changes, market competition, and global economic conditions affecting the pharmaceutical industry. Adverse events related to drug approvals or clinical trials could also impact the stock's movement. Analysis Summary: Alivus Life Sciences Ltd presents a promising technical setup with identified support and target levels. Neutral to bullish indicators like RSI and moving averages, coupled with strong volume activity, suggest investor interest. However, sector-specific risks and broader market conditions should be carefully considered. This analysis is for informational purposes and does not constitute a direct buy/sell recommendation.
NSE:ALIVUSLong
by TechnicalAnalystSucrit
AMBUJA CEMENTS Stock Overview: Ambuja Cements Ltd, traded on the NSE, current price: ₹532.45. Ambuja Cements Ltd is a major cement manufacturing company in India, producing and selling cement and clinker. Key Levels: Support (yellow zone): ₹399.10, ₹432.00, ₹464.90 Swing Zone (green zone): ₹512.95 - ₹550.05 Technical Indicators: RSI (Relative Strength Index): Currently at 49.33, indicating neutral momentum as it is near the midpoint of 50. Volume: 13.99M, showing significant trading activity. MA (Moving Averages): The stock price is above the 200-day MA (₹549.14) but below the 50-day MA (₹516.90), signaling mixed trends. Sector and Market Context: Ambuja Cements Ltd operates in the construction materials sector, which has been experiencing moderate growth. The overall market trends show a recovery phase post-pandemic, with infrastructure development being a key driver. Risk Considerations: Potential risks include fluctuations in raw material prices, regulatory changes, and economic downturns that could impact construction activities. Market conditions such as interest rate changes and global economic events might also influence the stock's movement. Analysis Summary: Ambuja Cements Ltd shows a mixed technical outlook with neutral RSI and significant trading volume. The stock is in a swing zone with key support and target levels identified. Investors should consider sector performance and market conditions while evaluating this stock.
NSE:AMBUJACEMLong
by TechnicalAnalystSucrit
AXIS BANKTechnical Analysis Report Stock Overview: Axis Bank Ltd - NSE - Current Price: ₹1,097.85. Axis Bank Ltd is a prominent private sector bank in India, offering a wide range of financial services, including retail banking, corporate banking, and treasury operations. Key Levels: Support (Yellow Zone): ₹926.70 - ₹952.52 Swing Zone (Green Zone): ₹1,015.00 - ₹1,091.53 Technical Indicators: RSI (Relative Strength Index): The RSI value is 52.62, indicating neutral momentum as it is close to the midpoint of 50. Volume: The trading volume is 8.28M, reflecting moderate investor interest. Higher volume often signals stronger price movements. MA (Moving Average): The stock is trading above its 50-day moving average (₹1,091.53) but below its 200-day moving average (₹952.52), suggesting a mixed trend. Sector and Market Context: Axis Bank operates in the financial sector, which has been experiencing fluctuations due to economic conditions, interest rate changes, and regulatory policies. While the overall market shows signs of recovery, uncertainties persist, impacting the banking sector's performance. Risk Considerations: Potential risks include changes in interest rates, regulatory shifts, economic downturns, and geopolitical events. These factors could influence the stock's movement and overall market sentiment. Analysis Summary: Axis Bank Ltd presents a mixed technical outlook with identified support and resistance levels. The RSI indicates neutral momentum, and the volume suggests moderate investor interest. Moving averages provide a mixed trend signal. Investors should carefully consider sector and market conditions, along with potential risks, before making investment decisions.
NSE:AXISBANKLong
by TechnicalAnalystSucrit
2
ready for targets MARUTI SUZUKI Stock Overview: Maruti Suzuki India Ltd., traded on NSE, current price: ₹11,732.80. Maruti Suzuki India Ltd. is a leading automobile manufacturer in India, primarily engaged in the production and sale of passenger vehicles. Technical Indicators: RSI (Relative Strength Index): The RSI value is 47.68, indicating neutral momentum as it is neither in the overbought (>70) nor oversold (<30) zone. Volume: The trading volume is 2.07 million, reflecting moderate activity. MA (Moving Averages): Multiple moving averages (e.g., 50, 200-day SMA) suggest trend direction and potential support/resistance levels. Sector and Market Context: Maruti Suzuki operates in the automobile sector, which is witnessing fluctuations due to evolving consumer demand, regulatory policies, and economic conditions. The sector is also influenced by the growing focus on electric vehicles and sustainability. The broader market shows signs of recovery post-pandemic, which could positively impact the automobile industry. Risk Considerations: Potential risks include market volatility, changes in government policies, global economic conditions, supply chain disruptions, and competition from other manufacturers. Additionally, fluctuations in raw material prices and foreign exchange rates could affect performance. Analysis Summary: Maruti Suzuki India Ltd. exhibits neutral momentum with moderate trading activity. The stock is currently in a swing zone, with potential targets identified. Investors should carefully consider market conditions, sector performance, and associated risks before making decisions.
NSE:MARUTILong
by TechnicalAnalystSucrit
Positional or Longterm Opportunity in KfinechGo Long @ 918.55 for Targets of 1109.65, 1205.2, 1300.75, and 1491.85 with SL 439.15 Reasons to go Long : 1. On a Weekly timeframe if we draw the Fibonacci retracement tool from the recent swing low (point A) to the recent swing high (point B) then we see stock took support from the 0.618 Fibonacci level. 2. Besides, a bullish candlestick pattern Bullish Hammer (marked with orange) is formed around the 0.618 Fibonacci level. 3. In addition to this there is a strong demand zone (marked with purple) which earlier was acting like resistance but now is providing support to the stock. 4. There is also a strong Trendline (marked with green) that is providing support to the stock.
NSE:KFINTECHLong
by Nimish_Ghagare
LTIM Trades Sideways After Market Correction Topic Statement: LTIM has corrected along with the broad market correction and is currently trading in a sideways range, with key support and resistance levels defining its movement. Key points: - The stock is moving in a sideways range between 4000 and 6000. - Price has received heavy support at the 50% retracement level previously and is currently at this level. - The stock is trading below the 180-day exponential moving average, making it oversold. - The weekly MFI is at 17.8, indicating that the stock is highly oversold.
NSE:LTIMLong
by yogeshwar
1
Mankind Pharma: Fundamental & Technical Analysis for TradersFinancial Performance Overview Mankind Pharma, a leading player in the pharmaceutical sector, recently released its Q3 financial results for the period ending December 31, 2024. The company reported a 16.5% decline in net profit, falling to ₹384 crore from ₹460 crore in the same quarter last year. This decline was primarily due to increased expenses, including costs related to the acquisition of Bharat Serums and Vaccines in October 2024. Despite the profit decline, the company saw a strong revenue growth of 24%, with revenue from operations rising to ₹3,230 crore from ₹2,607 crore year-over-year. This surge is largely driven by an increased market share in chronic illness drugs, which grew to 37.6% from 35.6%. The company's market capitalization stands at ₹99,640 crore, with a P/E ratio of 45.16. Technical Analysis & Trading Outlook Current Market Price (CMP): ₹2,415.05 Chart Pattern: The stock recently formed a falling wedge pattern on the daily time frame (TF) and gave a breakout with a significant volume increase of 2.36M. Breakout Confirmation: If the price closes above ₹2,442, we can expect a strong bullish move. Upside Targets Post-Breakout: Short-term Target: ₹2,610 Medium-term Target: ₹2,750 Long-term Target: ₹3,002 Potential Downside & Reversal Zone If the price experiences a pullback, we can expect a reversal zone between ₹2,253 - ₹2,336. A bounce from this level could trigger bullish momentum, offering an ideal re-entry point for traders. With strong revenue growth, technical breakout confirmation, and a well-defined support zone, Mankind Pharma remains a stock to watch for both fundamental investors and technical traders. Disclaimer: This analysis is for educational purposes only. Investors should conduct their own research before making any trading decisions.
NSE:MANKIND
by Alice Blue
NIFTY 50 : Fibonacci Levels and Potential MovementsLooking at the recent Fibonacci retracements on Nifty, we’ve observed a pattern where the price tends to reverse from the 0.5 level and move towards the 1.47 extension level. Let’s take a closer look at the last three Fibonacci retracements: 1) 26777 to 23263 2) 24857 to 23460 3) 24857 to 22786 Now, if we plot Fibonacci from 24857 to 21965, the 0.5 level comes out to 23415. As we’ve seen in previous cases, the price tends to return from the 0.5 level. If Nifty forms a red candle on a daily basis at this level (23415) and the next candle breaks the low of the previous candle, then there is a possibility for Nifty to reach the 1.47 extension level, which is around 20600.
NSE:NIFTY
by arnavijaygupta
HINDUSTAN FOODSStock Overview Hindustan Foods Ltd, traded on NSE, current price: INR 564.90. The company specializes in manufacturing food products and beverages. Key Levels Support (Yellow Zone): INR 415.35 - INR 486.70 Swing Zone (Green Zone): INR 531.25 - INR 572.85 Target Levels (T): INR 726.30, INR 797.65, INR 888.45, INR 1,150.80 Technical Indicators RSI (Relative Strength Index): Currently at 53.55, indicating neutral momentum as it is neither overbought (>70) nor oversold (<30). Volume: 395.38K, reflecting active trading and interest in the stock. MA (Moving Average): The stock price is above the 200-day moving average, suggesting a potential bullish trend. Sector and Market Context Hindustan Foods Ltd operates within the consumer goods sector, which has demonstrated resilience and steady growth. The broader market trend has been positive, with consumer goods stocks benefiting from increased demand and economic recovery. Risk Considerations Potential risks include: Market volatility. Shifts in consumer preferences. Regulatory changes. Economic downturns that could impact performance. Analysis Summary Hindustan Foods Ltd exhibits stable performance with clearly defined support and resistance levels. Technical indicators suggest a neutral to bullish outlook. Investors should consider the broader market conditions and sector performance while making decisions, keeping in mind the identified risks.
NSE:HNDFDSLong
by TechnicalAnalystSucrit
Dixon Corrects After Strong Bull Run Topic statement: Dixon was on a strong bullish streak, becoming overbought, and has finally faced a correction after breaching its up trendline, leading to increased selling pressure. Key points: - The up trendline was breached, triggering selling pressure. - Price has taken support at the 38.2% retracement level. - The stock is still above the 90-day EMA, and the weekly MFI is at 30. - If the 38.2% retracement level fails to hold, further correction to the 50% retracement level is possible.
NSE:DIXON
by yogeshwar
ready for cheers RADICO KHAITANStock Overview: Stock Name: Radico Khaitan Ltd, Exchange: NSE Company Business Profile: Radico Khaitan Ltd is a leading Indian company specializing in the manufacturing and distribution of alcoholic beverages, including spirits and liquors. Key Levels: Support (Yellow Zone): ₹1,688.35 - ₹1,891.25 Swing Zone (Green Zone): ₹2,032.45 - ₹2,148.10 Technical Indicators: RSI (Relative Strength Index): Currently at 53.69, indicating neutral momentum. RSI values above 70 suggest overbought conditions, while below 30 indicate oversold conditions. Volume: 410.85K shares traded, reflecting moderate activity. Higher volume often signals increased interest in the stock. MA (Moving Averages): The stock price is above the 200-day moving average (₹1,437.52), suggesting a long-term uptrend. Sector and Market Context: Radico Khaitan Ltd operates within the alcoholic beverages sector, which is influenced by regulatory changes, consumer trends, and economic conditions. The sector shows resilience, and the stock's position above its long-term moving average aligns with the broader bullish market sentiment. Risk Considerations: Potential risks include regulatory changes impacting the alcoholic beverages industry, fluctuations in raw material costs, and shifts in consumer preferences. Broader market conditions, such as economic downturns or geopolitical events, could also affect the stock's performance. Analysis Summary: Radico Khaitan Ltd demonstrates a strong upward trend, supported by key technical levels and indicators. While the long-term outlook appears positive, investors should remain cautious of potential risks and market conditions. This analysis is for informational purposes only and does not constitute investment advice.
NSE:RADICOLong
by TechnicalAnalystSucrit
ready for targets GUJARAT THEMISStock Overview Gujarat Themis Biosyn Ltd (NSE: GTBL) is currently trading at ₹257.90. The company operates in the pharmaceutical and biotechnology sector, focusing on fermentation-based active pharmaceutical ingredients (APIs). Technical Indicators RSI (Relative Strength Index): Currently at 54.52, indicating a neutral stance. It suggests neither overbought nor oversold conditions, leaving room for further price movement in either direction. Volume: The recent volume stands at 27.14K, showing moderate participation. Increased volume around support or breakout levels could confirm the trend. Moving Averages (MA): The stock appears to be trending above a rising support channel, indicating a potential uptrend continuation if it holds above the key levels. Sector and Market Context The pharmaceutical and biotechnology sector has been witnessing moderate growth, driven by increasing demand for healthcare products. However, sector rotation and overall market sentiment may impact GTBL’s movement. The NIFTY Pharma Index's performance should be monitored for broader trends.
NSE:GUJTHEMLong
by TechnicalAnalystSucrit
IndusInd Bank Plunges on Accounting ConcernsTopic Statement: IndusInd Bank has faced a massive selloff following accounting discrepancies in its derivatives portfolio, pushing the stock into oversold territory. Key points: - Stock has broken the 61.8% retracement level, indicating the selling pressure may continue until a full 100% retracement towards Rs 243. - Price has overextended below the 180-day EMA, making the stock oversold. - MFI on the weekly chart is at 20, denoting highly oversold conditions.
NSE:INDUSINDBK
by yogeshwar